Endometrioid adenocarcinoma of ovary (Q38910): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Adenocarcinoma endometrioide originando-se do ovário. Compreende de 10% a 25% de todos os carcinomas ovarianos primários. Grosseiramente, o carcinoma endometrioide pode se apresentar como uma massa cística ou sólida. Microscopicamente, o tumor se assemelha muito à aparência do tipo comum de adenocarcinoma endometrial. Como grupo, o carcinoma endometrioide tem um prognóstico duas vezes melhor do que o do carcinoma seroso ou mucinoso.
description / endescription / en
 
An endometrioid adenocarcinoma arising from the ovary. It comprises 10% to 25% of all primary ovarian carcinomas. Grossly, endometrioid carcinoma may present as a cystic or solid mass. Microscopically, the tumour greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma. As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.

Revision as of 04:10, 13 August 2026

An endometrioid adenocarcinoma arising from the ovary. It comprises 10% to 25% of all primary ovarian carcinomas. Grossly, endometrioid carcinoma may present as a cystic or solid mass. Microscopically, the tumour greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma. As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.
Language Label Description Also known as
default for all languages
2C73.01
    English
    Endometrioid adenocarcinoma of ovary
    An endometrioid adenocarcinoma arising from the ovary. It comprises 10% to 25% of all primary ovarian carcinomas. Grossly, endometrioid carcinoma may present as a cystic or solid mass. Microscopically, the tumour greatly resembles the appearance of the ordinary type of endometrial adenocarcinoma. As a group, endometrioid carcinoma has a prognosis twice as good as that of serous or mucinous carcinoma.

      Statements